Rejected at 10:10 p.m. Feb, 18, 2024 ] by herstein.jacob
Author: ansleyha
Related Note: 1499811378817
Rationale for change

CDC Yellow Book says Nitazoxanide is FDA approved for use in immunocompetent only and has not been proven to help in immunosuppressed. It is a typo in First Aid 2023.

Rejection reason

Not an accepted source

Extra Extra
Text
{{c2::Nitazoxanide}} is an antiprotozoal used exclusively* in {{c1::immunocompetent}} hosts to treat {{c3::Cryptosporidium}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo

OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#B&B::13_Infectious_Disease::05_Parasites_and_Helminths::02_Protozoa::Extra #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Step1_v12::#Physeo::06_Micro::04_Parasites::03_Cryptosporidium_Spp. #AK_Original_Decks::Step_1::Lolnotacop::Bugs !AK_UpdateTags::Step1decks::Lolnotacop::Bugs #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#SketchyMicro::04_Parasites::01_Protozoa_of_the_Intestinal_Tract::03_Cryptosporidium_spp. #AK_Step1_v12::#Bootcamp::Microbiology::20_Gastrointestinal_Protozoa::03_Cryptosporidium !AK_UpdateTags::AnKing_Image::MS::Intestinal_protozoa #AK_Step2_v12::#B&B::08_Infectious_Disease::02_Fungi_and_Parasites::03_Protozoal_Infections::Extra #AK_Step1_v12::#FirstAid::03_Microbiology::04_Parasitology::01_Protozoa-gastrointestinal_infections::*Cryptosporidium #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_5::Parasites::Protozoa